Official websites use .gov
Secure .gov websites use HTTPS
« Previous
Next »
Titles
- Cost savings2
- Competitive bidding in drug procurement: evidence from China1
- Congreso Internacional de Derecho y Economia Farmaceutica1
- Drug discount program: federal oversight of compliance at 340B contract pharmacies needs improvement : report to Congressional requesters1
- Drug discount program: improvements needed in federal oversight of compliance at 340B contract pharmacies : testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives1
- Drug discount program: status of agency efforts to improve 340B program oversight : testimony before the Committee on Health, Education, Labor, and Pensions, U.S. Senate1
- Drug price moderation in Germany: lessons for U.S. reform efforts1
- Equilibrium effects of pharmaceutical bundling: evidence from India1
- Indication-specific pricing of pharmaceuticals in the United States health care system: a report from the 2015 ICER Membership Policy Summit1
- Medicaid's most costly outpatient drugs1
- Navigating the pharmacy benefits marketplace1
- Research and development in the pharmaceutical industry1
- Survey brief: drug companies reduce patients’ access to care by limiting 340B community pharmacies1
- The Medicaid Drug Rebate Program: the basics1
- The role of clinical and cost information in Medicaid pharmacy benefit decisions: experience in seven states1